The role of CXCR4 signaling in promoting proliferation and survival was supported by the in vitro studies, where the high-affinity CXCR4 inhibitor BTK140 alone resulted in inhibited proliferation as well as inhibitory changes of adhesion and growth patterns in various DLBCL cell lines. This evidence concerns the gene CXCR4 and diffuse large B-cell lymphoma.